search for




 

Changes in Salivary Parameters, Halitosis, Oral Health, and Systemic Disease with Increasing Age
J Oral Med Pain 2024;49:124-134
Published online December 30, 2024;  https://doi.org/10.14476/jomp.2024.49.4.124
© 2024 Korean Academy of Orofacial Pain and Oral Medicine

Solsol Seo1│Tae-Seok Kim1│Yeon-Hee Lee1,2

1Department of Dentistry, Graduate School, Kyung Hee University, Seoul, Korea
2Department of Orofacial Pain and Oral Medicine, Kyung Hee University Dental Hospital, College of Dentistry, Kyung Hee University, Seoul, Korea
Correspondence to: Yeon-Hee Lee
Department of Orofacial Pain and Oral Medicine, Kyung Hee University Dental Hospital, College of Dentistry, Kyung Hee University, 23 Kyunghee-daero, Dongdaemun-gu, Seoul 02447, Korea.
E-mail: omod0209@gmail.com
https://orcid.org/0000-0001-7323-0411
Received November 29, 2024; Revised December 8, 2024; Accepted December 9, 2024.
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Purpose: The elderly population in South Korea is steadily increasing, ushering in the super-aging era and emphasizing the need for oral health management. This study aimed to investigate changes in salivary flow rate, salivary buffer capacity, halitosis, oral health, and systemic diseases with age.
Methods: This study was conducted retrospectively from August 2020 to May 2023, including 274 patients (66 males, 208 females; mean age 59.39±16.10 years) presenting with xerostomia or halitosis.
Results: For salivary parameters, no significant differences were observed in unstimulated salivary flow rate, stimulated salivary flow rate, salivary pH, or buffer capacity across age groups (all p>0.05), contrary to expectations. Regarding halitosis, methyl mercaptan levels were significantly associated with age (p=0.049), though patients in their 20s exhibited the highest levels. Volatile sulfur compound levels showed a strong correlation with subjective halitosis (r=0.621, p<0.001). In terms of oral health, increased age was significantly associated with tongue coating (r=0.205, p=0.001). Among systemic diseases, hypertension (p=0.001) and diabetes (p=0.010) showed significant differences across age groups. The drug that showed a statistically significant correlation with increasing age was amlodipine (r=0.249, p=0.001), a widely used antihypertensive agent. Amlodipine usage was significantly associated with oral hygiene issues, sticky saliva, calculus deposition, and tongue coating (all p<0.05). The results highlight the changes in salivary parameters and other oral and systemic factors with age, along with their interrelationships.
Conclusions: These findings provide valuable insights to aid clinicians in developing optimal treatment plans for xerostomia and halitosis and in effectively managing oral health in the elderly population.
Keywords : Age; Aging; Halitosis; Oral health; Salivary flow rate; Systemic disease
INTRODUCTION

South Korea is entering the age of super-aging society. The 2015 Census of Older People estimates that proportion of those who aged 65 and over in South Korea is 13.2%, and forecasts that the proportion will continue to rise and reach 20.0% in 2025, entering the super-aging society [1,2]. In the era of super-aging society, the importance of maintaining general health of elderly is steadily increasing, and one of the crucial factors in general healthcare of elderly is managing oral health. Neglecting oral health management can lead to several oral diseases such as dental caries and periodontal disease, which can affect systemic health [3]. Especially, oral infectious diseases are definitive causal factors for systemic diseases, as oral microbial toxins and inflammations can spread to systemic conditions through metastatic inflammation, transient bacteremia, or aspiration pneumonia [4,5]. Risk for this oral health-related systemic disease is especially higher in elderly. Several characteristics of elderly such as decreased function of immune system, xerostomia, medication can make oral health management difficult, and increase the possibility that spread of oral infection would not be well controlled in elderly [6].

Thus, oral infectious disease is particularly important in elderly. For proper management of oral infectious disease, the understand of common oral infectious diseases as well as factors that can make elderly vulnerable to infection is important, which include dental caries, periodontitis, as well as xerostomia, halitosis, oral candidiasis, and systemic diseases. Xerostomia is very common oral condition, featuring with subjective sense of oral dryness [7]. Prevalence of xerostomia is 9.3% to 64.8% depending on studies, and it tends to increase in elderly [8-10]. Main causes of xerostomia include dysfunction of salivary gland, radiation therapy, chemotherapy, medication, and systemic diseases [11,12]. Symptoms of xerostomia include dryness, speech disturbances, and difficulty in chewing and swallowing food, which can impair the oral self-cleansing mechanism and thereby increase the risk and spread of oral infections [13].

Halitosis is also one of the common oral diseases among the elderly. Oral health problems account for more than 90% of the causes of halitosis, and the most common cause was tongue coating, and others were including periodontal disease, xerostomia, dental plaque, and faulty prostheses [14-16]. These oral health problems and halitosis share the common denominator, the oral infection from oral microbiome. Imbalanced oral microbiota caused by poor oral hygiene can cause several oral health problems, and produce volatile sulfur compounds (VSCs), which is the direct cause of halitosis [14]. Halitosis can significantly impact both oral and systemic health, as hydrogen sulfide (H2S), one of the major components of VSCs, plays a crucial role in regulating cellular activities such as inflammation, apoptosis, and cell differentiation [17]. Notably, in the elderly, the distribution of the oral microbiome undergoes significant changes, characterized by a shift in dominant species, decreased diversity, and an increase in enteropathogens. These changes elevate the risk of both oral and systemic diseases [18,19], highlighting the critical importance of oral health management in the elderly.

Although needs to understand oral health condition and related oral and systemic disease are getting more important, previous studies about xerostomia, halitosis, and oral health of elderly are still insufficient, and their correlation with age is not fully investigated. This study aims to assess the level of halitosis and salivary parameters across different age groups and to investigate the association between age, halitosis, and salivary characteristics. In addition, this study aims to investigate the status of oral health and medication according to age, and their correlation with salivary flow rate and salivary buffer capacity. Main hypothesis of this study is that elderly will show decreased salivary flow rate and salivary buffer capacity, and have higher prevalence of halitosis, systemic disease, and poor oral health than younger counterparts. Additional hypothesis is that xerostomia, halitosis, oral health condition, systemic disease, and medication will interact have correlation with each other.

MATERIALS AND METHODS

1. Research Subjects and Groups

This study targeted patients aged between teens to 80s who visited the Department of Orofacial Pain and Oral Medicine at Kyung Hee University Dental Hospital from August 2020 to May 2023, complaining xerostomia or halitosis. For sample size calculation, we used G*Power software (ver. 3.1.9.7, Heinrich-Heine-Universität Düsseldorf), found that 220 participants were suitable for statistical analysis (α level=0.05, the power=0.90, and the effect size=0.5). After screening, 303 patients were selected, and 29 patients were excluded due to the insufficient medical records. A total 274 patients (66 males, 208 females, mean age 59.39±16.10 years) were enrolled in this study. Patients were then divided into eight age groups according to 10-year increments: teens into age group 1, 20s into age group 2, and so on until age group 8.

2. Evaluation of Saliva and Halitosis

Evaluation of salivary parameters was performed at the patients’ initial visit, using GC Saliva Check Buffer kits (GC Company). Evaluated salivary parameters were salivary flow rate, salivary pH, and salivary buffer capacity, using the spitting method. First, patients were ordered to spit their saliva for 10 minutes in resting state. The amount of collected saliva was recorded as unstimulated flow rate (UFR). After measuring UFR, a salivary pH test strip was inserted into the unstimulated whole saliva, and salivary pH was recorded according to the color change of test strip (Fig. 1A). Next, patients were instructed to chew paraffin wax gum for 2 minutes, and spit their saliva for 5 minutes. This amount of collected saliva was recorded as stimulated flow rate (SFR). After measuring SFR, stimulated whole saliva was dropped onto the buffer test strip using a pipette, and salivary buffer capacity was recorded according to the color change of buffer test strip with the salivary buffer indicator (Fig. 1B). In terms of diagnosis criteria, normal UFR is 0.3-0.4 mL/min, and normal SFR is 1.5-2.0 mL, while hyposalivation is diagnosed when UFR is under 0.1 mL/min or SFR is under 0.7 mL/min [20]. Normal salivary pH is between 6.7-7.3, and abnormal salivary pH is under 6.3 [21]. Additionally, since there are several measuring methods for salivary buffer capacity, this study followed the guideline of manufacturer of salivary test kit, GC company, where score between 10-12 is normal salivary buffer capacity, 6-9 is low, and 0-5 is very low. All of the salivary evaluation procedures were performed by skilled dentists and dental hygienists, trained in standardized examination protocol.

3. Evaluation of Halitosis

The level of halitosis was assessed during the patients’ initial visit. Halitosis was evaluated using the Oral Chroma Twin Breasor II (iSenLab), which separates and measures H2S and methyl mercaptan (CH3SH) in parts per billion (ppb). For gas collection, a syringe was carefully inserted deep into the patients’ oral cavity, avoiding contact with the tongue or saliva, while the mouth remained closed. The collected gas was then introduced into the device for analysis, and the results were recorded (Fig. 1C). The VSC level was calculated as the sum of H2S and CH3SH concentrations. An abnormal VSC level was diagnosed when H2S exceeded 112 ppb or CH3SH exceeded 26 ppb [22].

4. Evaluation of Oral Health Condition

Before the oral health examination, patients were asked for the reason of visit, and it was classified into five categories: stomatitis, glossodynia, xerostomia, halitosis, and taste disorder. Then oral health condition was evaluated and recorded by examination of skilled dentists. Patients rated their oral discomfort using a visual analog scale, with scores recorded on a scale from 0 to 10. Sticky saliva was checked when frosty or viscous saliva is observed with the naked eye. Oral hygiene was recorded with three grades of good, acceptable, and poor, according to the subjective judgment of clinician. Calculus deposition was evaluated in three levels according to the subjective judgment of clinician: none, where no visible calculus was observed; moderate, where visible calculus was observed in some teeth; and severe, where visible calculus was observed in almost all teeth. Tongue coating was checked if patients had white or yellowish tongue coating on the posterior 2/3 of tongue. Ulcer was checked if patients had any visible ulcer in oral mucosa. Oral candidiasis was evaluated by two categories: clinical impression of candidiasis and oral candidiasis. Clinical impression of candidiasis was checked if patients had any typical clinical symptoms of oral candidiasis, including tongue coating, tongue atrophy, or angular cheilitis. Oral candidiasis was checked if patients were proven to have oral fungus by swab culture, which was performed by collecting oral specimen with sterile transport swab (Transystem, COPAN), culturing in the medium, and evaluating the observed specimen. All of the culture procedure were following the criteria of the Department of Laboratory Medicine of Kyung Hee University Medical Center.

5. Evaluation of Systemic Disease and Medication

Systemic diseases and medication of patients were collected from the questionnaire at the patients’ initial visit. Systemic diseases were categorized into hypertension, diabetes, osteoporosis, and heart disease, which are the four most prevalent systemic diseases. Patients with overlapping conditions among these categories were included in each relevant group. Medications prescribed to patients were also recorded and classified into four categories: Amlodipine tab (amlodipine), for hypertension; Metformin tab (metformin), for diabetes; Alend tab (alendronate), for osteoporosis; and Lasix tab (furosemide), for heart and cardiovascular diseases.

6. Statistical Analysis

The data were analyzed using the IBM SPSS for Windows (version 26.0, IBM Corp.). Descriptive statistics were used to calculate means and standard deviations. To analyze the distribution of discontinuous data, we used the χ2 and Bonferroni tests for the equality of proportions. Analysis of variance and Tukey’s post-hoc test were used to compare the values of parameters among the age groups. Spearman’s correlation analysis was used to determine factors associated with ageing and the other oral and systemic parameters. The correlation coefficients (r) indicate the strength of the correlation and range between −1 and 1; the closer the absolute value of r is to 1, the stronger is the relationship. For all analyses, the statistical significance was set at a two-tailed p-value<0.05.

7. Ethics Approval and Consent to Participate

The procedures for human subjects in this study were conducted according to the ethical standards of the Committee on Human Experimentation of our institution and the 1975 Declaration of Helsinki. This study was approved by the appropriate ethics review board of the Kyung Hee University Dental Hospital (IRB No. KH-DT23022). Informed consent was obtained from all participants in this study.

RESULTS

1. Sex and Age Distribution of Patients

A total of 274 participants were included in this study. Of these, 66 (22.8%) were male, and 208 (71.7%) were female. The distribution of participants across age groups was as follows: 9 individuals (3.3%) in their teens (age group 1), 10 (3.6%) in their 20s (age group 2), 11 (4.0%) in their 30s (age group 3), 30 (10.9%) in their 40s (age group 4), 63 (23.0%) in their 50s (age group 5), 66 (24.1%) in their 60s (age group 6), 67 (24.5%) in their 70s (age group 7), and 18 (6.6%) in their 80s (age group 8). The mean age of the participants was 59.39±16.10 years.

2. Salivary Parameters by Age Group

The salivary parameters across different age groups are presented in Fig. 2. Across the age groups, there was no significant difference in the UFR (p=0.229), SFR (p=0.971), salivary pH (p=0.606), and salivary buffer capacity (p=0.344). For UFR, age group 2 had the lowest mean value (0.28±0.18 mL/min) and age group 8 had the highest mean value (0.60±0.36 mL/min). For SFR, age group 1 had the lowest mean value (1.27±0.39 mL/min) and age group 8 had the highest mean value (1.51±0.64 mL/min). All of the age groups were in the normal range of salivary flow rate. For salivary pH, age group 2 had abnormal salivary pH (6.18±0.62), which was the lowest mean value among the age groups. Additionally, most age groups exhibited slightly lower salivary pH than the normal range, except for age group 8, which had a mean value of 6.77±0.63. For salivary buffer capacity, only age group 1 (10.67±1.22) and age group 3 (10.82±1.25) had normal salivary buffer capacity. Other age groups had lower salivary buffer capacity than normal range, and age group 2 had the lowest mean value (9.00±2.67).

3. Volatile Sulfur Compound Levels by Age Group

The VSC levels across different age groups are shown in Fig. 3. Age group 2 showed significantly higher mean level of CH3SH (152.00±214.96 ppb) than the other age groups (p=0.049). For H2S, age group 2 had the highest mean value (410.00±579.82 ppb) followed by age group 3 (318.50±635.00 ppb). However, relationship between H2S and age groups was not statistically significant (p=0.393). For VSC, age group 2 had the highest mean value (112.40±355.44 ppb), but it was not statistically significant difference with the other age groups (p=0.051).

4. Distribution of Representative Systemic Diseases by Age Group

The distribution of the four representative systemic diseases is shown in Fig. 4. There was a significant difference in the prevalence of hypertension across the age groups (p=0.001), with a significantly higher incidence observed in the older age groups (age groups 7 and 8) compared to the other age groups. Similarly, the prevalence of diabetes also differed significantly across the age groups (p=0.010), with a higher incidence in age groups 7 and 8. In contrast, the differences in the prevalence of osteoporosis (p=0.099) and heart disease (p=0.235) across the age groups were not statistically significant.

5. Correlation between Age, Halitosis, and Salivary Flow Rate

Table 1 displays the result of correlation analysis between age, halitosis, salivary flow rate, and oral candidiasis. VSC and complaint of halitosis were strongly correlated (r=0.621, p<0.001). UFR and SFR also showed a statistically strong correlation (r=0.513, p<0.001).

6. Correlations of Age, Salivary Flow Rate, Medications, Halitosis, and Oral Health Conditions

This study examined the correlations between, medications, oral conditions, halitosis and salivary flow rate. The results of correlation analysis are presented in Table 2. Age was significantly related with amlodipine (r=0.249, p=0.001) and tongue coating (r=0.205, p=0.001). Among the medications, amlodipine was a significant factor in multiple medications and oral status. Amlodipine usage was significantly associated with age (r=0.249, p<0.001), metformin usage (r=0.243, p<0.001), alendronate usage (r=0.232, p<0.001), oral hygiene (r=0.208, p=0.001), sticky saliva (r=0.180, p=0.003), calculus deposition (r=0.169, p=0.005), tongue coating (r=0.134, p=0.027), and SFR (r=0.131, p=0.030). Additionally, metformin usage was significantly related with calculus deposition (r=0.135, p=0.025), and alendronate usage had a significant relationship was sticky saliva (r=0.140, p=0.021). Furthermore, sticky saliva was significantly correlated with VSC levels (r=0.183, p=0.002).

7. Salivary Flow Rate and Buffer Capacity according to Oral Diseases

Five oral diseases, which were the reason of visit, were examined and categorized: Group 1 was categorized as stomatitis, Group 2 as glossodynia, Group 3 as xerostomia, Group 4 as halitosis, and Group 5 as taste disorder. Correlation with saliva for each group was analyzed, and the results are displayed in Table 3. Salivary pH was significantly higher in Group 5 (7.50±0.58) than other groups (p=0.023). The mean value of UFR was highest in Group 5 (0.50±0.58 mL/min) and lowest in Group 4 (0.15±0.38 mL/min), but the difference was not significant (p=0.528). SFR was highest in Group 5 (2.25±0.50 mL/min) and lowest in Group 3 (1.27±0.84 mL/min), but the difference was not significant (p=0.051). Salivary buffer capacity was highest in Group 5 (11.25±1.50 mL/min) and lowest in Group 4 (8.85±2.44 mL/min), but the difference was not significant (p=0.501).

DISCUSSION

In this study, we aimed to investigate the changes in salivary parameters, halitosis, systemic diseases, and oral health conditions with increasing age, as well as to examine the correlations among these factors. The results showed that amlodipine usage and tongue coating were closely associated with increasing age, whereas salivary parameters and halitosis did not exhibit significant relationships with age. Regarding to age groups, CH3SH level was significantly higher in age group 2, and prevalence of hypertension and diabetes was significantly higher in age group 7 and 8. In contrast, H2S, VSC, all of the salivary parameters, prevalence of osteoporosis and heart disease were not significantly related with age groups. In addition, patients taking amlodipine were more likely to have sticky saliva, heavy calculus deposition, more tongue coating, poor oral hygiene, and lower SFR. Patients with taste disorder had significantly higher salivary pH.

In this study, CH3SH level was significantly higher in the 20s group compared to other age groups, which is contrary to the result of previous studies suggesting that halitosis is not clearly associated with age, or halitosis is more prevalent in elderly [23,24]. Among the oral microbiome, Firmicutes were strongly related with production of CH3SH, followed by Bacteroidetes [23]. The relative abundance of Firmicutes tends to increase, while that of Bacteroidetes decrease from childhood to elderly, and this increased ratio of Firmicutes could explain the increased prevalence of halitosis in elderly [25,26]. However, combined proportion of Firmicutes and Bacteroidetes in oral microbiome does not change drastically as age increases, and proportion of Firmicutes could increase in youngers with systemic disease or poor oral hygiene [18,27]. Hence, it’s not unusual that increased CH3SH level is observed in younger patients, and the results of this study can be possible. Further studies would be needed with more and broader participants to accurately verify this result.

Contrary to the main hypothesis, salivary flow rate and salivary buffer capacity were not significantly different across the age groups. This result contrasts with previous studies suggesting that whole salivary flow rate tends to decrease in the elderly [12,28]. While several studies consistently report that the UFR is significantly lower in the elderly, there is ongoing debate regarding whether the SFR also decreases with age [29,30]. SFR is mainly composed of saliva from parotid gland, whose function is not significantly decreased with increasing age, and thus it is possible that SFR is not significantly different with increasing age [29,31]. Also, regarding to UFR, a study reported that UFR is closely related with oral condition while SFR is not [31]. Since this study included only patients with oral discomfort, UFR of younger participants might be influenced to decrease by their poor oral condition, leading to the insignificant difference with elderly. Further studies would be needed to re-evaluate this result, with design of case-control study including healthy participants.

Regarding to the systemic disease, hypertension and diabetes were closely related with increasing age, which is corresponding to the previous studies [32,33]. Also amlodipine, which is antihypertensive drug, showed a significant relationship with several factors including sticky saliva, oral hygiene, calculus, tongue coating, and SFR in this study. This results are strongly emphasizing the importance of evaluating systemic disease and medication during oral health management in elderly. It is already well proven that systemic diseases as well as related medications and the oral health condition are strongly related [6,34]. Hypertension can cause angioedema, xerostomia or lichenoid reaction in oral mucosa, and patients with periodontal disease had increased risk for hypertension. And patients using antihypertensive drugs had higher risk of xerostomia, which was more severe in elderly [35]. Also, diabetes can cause xerostomia and imbalance of microorganisms in mouth, which can lead to taste disorder, increased risk of oral candidiasis, and periodontal disease. Since the prevalence of hypertension and diabetes in South Korea is steadily increasing [36,37], clinicians should even more carefully consider systemic disease during oral healthcare, especially in elderly.

Correlation analysis revealed the correlation of age with tongue coating. Tongue coating is comprised of several components including residual food, bacterial by-product, leukocytes, and keratinized products of degeneration, and thus tongue coating is closely related to the oral health and ability to manage oral condition [38]. Tongue coating is a significant contributing factor to certain oral diseases, including halitosis and taste disorders [39]. Tongue coating can also interact with systemic health, since microbiota in tongue coating can spread into respiratory or digestive system, affecting several metabolic pathways and causing disturbance of nitric oxide homeostasis, taste receptor dysfunction, and mucosal barrier destruction [40]. Thus, tongue coating can significantly impact both oral and systemic health; however, its exact etiology remains unidentified. Previous studies have suggested various potential contributing factors to tongue coating formation, including age, sex, oral hygiene, smoking, xerostomia, and systemic diseases. Nevertheless, the findings across studies remain controversial and require further validation [41]. Nevertheless, elderly patients had more tongue coating in this study, and this results would suggest the importance of oral health management in elderly.

In the analysis between oral disease groups and salivary function, salivary pH was significantly higher in taste disorder group. Alkaline state of saliva can be due to the interaction between oral bacteria and food debris, which can lead to plaque formation. However, excessive alkalinity of saliva can bring similar anaerobic conditions as academia, and their impact on oral conditions is almost same [21]. In previous studies, some reported that taste disorder is not closely related with salivary pH, while other reported that dysgeusia for certain taste is related with low pH [42,43]. Due to this controversial results, further studies should be needed to investigate relationship between taste disorder and salivary pH.

Despite the findings of this study, several limitations should be acknowledged. Primarily, evaluation of oral health was depending on the subjective judgement of examiners, and there might be lack of consistency. Additionally, adjustments for false discoveries were not applied during multiple correlation analyses, necessitating caution in interpreting the results. Nonetheless, this study provides valuable insights into correlations between age, salivary parameters, halitosis, oral health, and systemic disease.

In conclusion, this study comprehensively examined changes and correlations among salivary parameters, halitosis, oral health, and major systemic diseases across different age groups. While the correlation between aging, salivary parameters, and halitosis was less significant than anticipated, the study successfully identified relationships between aging, oral health, medication use, and systemic diseases. These findings highlight the importance of considering a broad range of factors in managing oral health, particularly in the context of an aging population. By raising local awareness and integrating these insights into treatment plans for xerostomia and halitosis, this study underscores the potential to enhance treatment efficiency, improve the quality of life, and support a stable lifestyle for the elderly.

CONFLICTS OF INTEREST

No potential conflict of interest relevant to this article was reported.

DATA AVAILABILITY STATEMENT

The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.

FUNDING

None.

AUTHOR CONTRIBUTIONS

Conceptualization: YHL, SS. Data curation: SS, TSK, YHL. Formal analysis: SS, TSK, YHL. Methodology: YHL, SS. Project administration: YHL, SS. Visualization: SS, TSK, YHL. Writing - original draft: SS, TSK, YHL. Writing - review & editing: SS, TSK, YHL.

Figures
Fig. 1. Evaluation of saliva characteristics and halitosis levels. (A) Test strip for salivary pH and dental saliva pH indicator. After applying the test strip to collected saliva, color of the test strip was compared to a standard color chart to determine the closest match. In the presented figure, salivary pH was interpreted as 7.4. (B) Paraffin wax, buffer strip, and salivary buffer indicator. Patients were indicated to chew paraffin wax to collect stimulated salivary flow rate. Collected stimulated saliva was dropped on buffer strip, and changed color was recorded. (C) Result page of halitosis evaluation. Levels of hydrogen sulfide (H2S), methyl mercaptan (CH3SH) were recorded.
Fig. 2. Salivary parameters across different age groups. (A) Salivary flow rate by age group. (B) Salivary pH by age group. (C) Salivary buffer capacity by age group. UFR, unstimulated flow rate; SFR, stimulated flow rate; Group 1, teens; Group 2, 20s; Group 3, 30s; Group 4, 40s; Group 5, 50s; Group 6, 60s; Group 7, 70s; Group 8, 80s. The results of this analysis were obtained by ANOVA and post-hoc analysis. There was no significant difference in salivary flow rate, salivary pH and buffer capacity across the age groups (all p>0.05).
Fig. 3. Comparison of H2S, CH3SH, and VSC levels across age groups. ppb, parts per billion; H2S, Hydrogen sulfide; CH3SH, methyl mercaptan; VSC, volatile sulfur compound; Group 1, teens; Group 2, 20s; Group 3, 30s; Group 4, 40s; Group 5, 50s; Group 6, 60s; Group 7, 70s; Group 8, 80s. The results of this analysis were obtained by ANOVA and post-hoc analysis. *p<0.05 indicates a significantly higher mean level of CH3SH in age group 2, compared with other age groups.
Fig. 4. Distribution of representative systemic diseases by age group. Group 1, teens; Group 2, 20s; Group 3, 30s; Group 4, 40s; Group 5, 50s; Group 6, 60s; Group 7, 70s; Group 8, 80s. The results of this analysis were obtained by Pearson chi-square test and post-hoc analysis. ***p<0.001 indicates a significant difference of prevalence of hypertension in age group 7 and 8, compared with age group 1 to 6. **p<0.01 indicates a significant difference of prevalence of diabetes in age group 7 and 8, compared with age group 1 to 6.
Tables

Correlations between age, halitosis, and salivary flow rate

Correlation VSC
(ppb)
Halitosis UFR
(mL/min)
SFR
(mL/min)
VAS Oral
candidiasis
Age Correlation coefficient 0.052 0.054 –0.024 0.082 0.012 –0.063
p-value 0.392 0.371 0.690 0.178 0.848 0.299
VSC (ppb) Correlation coefficient 1.000 0.621 0.038 0.083 –0.241 –0.020
p-value <0.001*** 0.533 0.171 <0.001*** 0.739
Halitosis Correlation coefficient 1.000 0.010 0.074 –0.116 –0.024
p-value 0.871 0.221 0.056 0.696
UFR (mL/min) Correlation coefficient 1.000 0.513 0.015 –0.012
p-value <0.001*** 0.801 0.841
SFR (mL/min) Correlation coefficient 1.000 –0.094 0.030
p-value 0.121 0.625
VAS Correlation coefficient 1.000 0.076
p-value 0.211

VSC, volatile sulfur compound; ppb, parts per billion; UFR, unstimulated flow rate; SFR, stimulated flow rate; VAS, visual analog scale.

The results of this analysis were obtained by Spearman correlation analysis.

Significance set at p<0.05. ***p<0.001.

Correlations between age, medications, oral health condition and halitosis

Correlation Amlodipine Metformin Alendronate Sticky saliva Oral
hygiene
Oral
candidiasis
Tongue coating Clinical
impression of
candidiasis
Calculus deposition VSC
Age 0.249 0.031 0.118 0.022 0.087 0.005 0.205 –0.063 –0.073 0.052
Amlodipine 0.243 0.232 0.180 0.208 0.169 0.134 –0.016 –0.017 0.007
Metformin 0.001 0.048 0.007 0.135 0.101 –0.058 –0.045 0.023
Alendronate 0.140 0.084 0.088 0.087 –0.019 –0.034 0.054
Sticky saliva 0.066 0.002 0.129 0.034 0.021 0.183
Oral hygiene 0.523 0.292 0.085 0.079 0.088
Oral candidiasis 0.357 0.025 0.026 0.060
Tongue coating 0.083 0.087 0.121
Clinical impression
of candidiasis
0.981 0.020
Calculus deposition 0.060

VSC, volatile sulfur compound; r, correlation coefficient.

The results of this analysis were obtained by Spearman correlation analysis.

Significance set at p<0.05.

The deeper the gray color, the stronger the correlation (with an r value approaching +1).

Salivary flow rate and buffer capacity in relation to oral diseases

Feature Group 1
(stomatitis)
Group 2
(glossodynia)
Group 3
(xerostomia)
Group 4
(halitosis)
Group 5
(taste disorder)
p-value Post-hoc
UFR (mL/min) 0.27±0.48 0.31±0.50 0.18±0.39 0.15±0.38 0.50±0.58 0.528 -
SFR (mL/min) 1.47±0.70 1.55±0.66 1.27±0.84 1.77±1.09 2.25±0.50 0.051 -
Salivary pH 6.45±0.73 6.59±0.74 6.36±0.65 6.69±0.63 7.50±0.58 0.023* Group 1, 2, 3, 4<5
Buffer capacity 9.68±2.46 9.49±2.44 9.44±2.76 8.85±2.44 11.25±1.50 0.501 -

UFR, unstimulated flow rate; SFR, stimulated flow rate; SD, standard deviation; -, not applicable.

Values are presented as mean±SD.

The results of this analysis were obtained by ANOVA and post-hoc analysis. p<0.05.

*p<0.05.

References
  1. Jang JY, Lee DH. Effects of oral health promotion program on oral function in the elderly. Korean J Health Serv Manag 2016;10:141-151.
    CrossRef
  2. Meng KH. Population aging and health promotion activities in Korea. J Korea Assoc Health Promot 2004;2:187-198.
  3. Richmond S, Chestnutt I, Shennan J, Brown R. The relationship of medical and dental factors to perceived general and dental health. Community Dent Oral Epidemiol 2007;35:89-97.
    Pubmed CrossRef
  4. Li X, Kolltveit KM, Tronstad L, Olsen I. Systemic diseases caused by oral infection. Clin Microbiol Rev 2000;13:547-558.
    Pubmed KoreaMed CrossRef
  5. Müller F. Oral hygiene reduces the mortality from aspiration pneumonia in frail elders. J Dent Res 2015;94(3 Suppl):14S-16S.
    Pubmed KoreaMed CrossRef
  6. Gil-Montoya JA, de Mello AL, Barrios R, Gonzalez-Moles MA, Bravo M. Oral health in the elderly patient and its impact on general well-being: a nonsystematic review. Clin Interv Aging 2015;10:461-467.
    Pubmed KoreaMed CrossRef
  7. Field EA, Fear S, Higham SM, et al. Age and medication are significant risk factors for xerostomia in an English population, attending general dental practice. Gerodontology 2001;18:21-24.
    Pubmed CrossRef
  8. Lee YH, Won JH, Auh QS, Noh YK, Lee SW. Prediction of xerostomia in elderly based on clinical characteristics and salivary flow rate with machine learning. Sci Rep 2024;14:3423.
    Pubmed KoreaMed CrossRef
  9. Fornari CB, Bergonci D, Stein CB, Agostini BA, Rigo L. Prevalence of xerostomia and its association with systemic diseases and medications in the elderly: a cross-sectional study. Sao Paulo Med J 2021;139:380-387.
    Pubmed KoreaMed CrossRef
  10. Jamieson LM, Thomson WM. Xerostomia: its prevalence and associations in the adult Australian population. Aust Dent J 2020;65(Suppl 1):S67-S70.
    Pubmed CrossRef
  11. Kim YJ. Xerostomia and its cellular targets. Int J Mol Sci 2023;24:5358.
    Pubmed KoreaMed CrossRef
  12. Liu B, Dion MR, Jurasic MM, Gibson G, Jones JA. Xerostomia and salivary hypofunction in vulnerable elders: prevalence and etiology. Oral Surg Oral Med Oral Pathol Oral Radiol 2012;114:52-60.
    Pubmed CrossRef
  13. Dodds MWJ, Haddou MB, Day JEL. The effect of gum chewing on xerostomia and salivary flow rate in elderly and medically compromised subjects: a systematic review and meta-analysis. BMC Oral Health 2023;23:406.
    Pubmed KoreaMed CrossRef
  14. Lee YH, Hong JY. Oral microbiome as a co-mediator of halitosis and periodontitis: a narrative review. Front Oral Health 2023;4:1229145.
    Pubmed KoreaMed CrossRef
  15. Setia S, Pannu P, Gambhir RS, Galhotra V, Ahluwalia P, Sofat A. Correlation of oral hygiene practices, smoking and oral health conditions with self perceived halitosis amongst undergraduate dental students. J Nat Sci Biol Med 2014;5:67-72.
    Pubmed KoreaMed CrossRef
  16. Spielman AI, Bivona P, Rifkin BR. Halitosis. A common oral problem. N Y State Dent J 1996;62:36-42.
  17. Wu DD, Ngowi EE, Zhai YK, et al. Role of hydrogen sulfide in oral disease. Oxid Med Cell Longev 2022;2022:1886277.
    Pubmed KoreaMed CrossRef
  18. Sarafidou K, Alexakou E, Talioti E, Bakopoulou A, Anastassiadou V. The oral microbiome in older adults-a state-of-the-art review. Archives Gerontol Geriatr Plus 2024;1:100061.
    CrossRef
  19. Kazarina A, Kuzmicka J, Bortkevica S, et al. Oral microbiome variations related to ageing: possible implications beyond oral health. Arch Microbiol 2023;205:116.
    Pubmed KoreaMed CrossRef
  20. Villa A, Connell CL, Abati S. Diagnosis and management of xerostomia and hyposalivation. Ther Clin Risk Manag 2015;11:45-51.
    Pubmed KoreaMed CrossRef
  21. Baliga S, Muglikar S, Kale R. Salivary pH: a diagnostic biomarker. J Indian Soc Periodontol 2013;17:461-465.
    Pubmed KoreaMed CrossRef
  22. Tonzetich J, Ng SK. Reduction of malodor by oral cleansing procedures. Oral Surg Oral Med Oral Pathol 1976;42:172-181.
    Pubmed CrossRef
  23. Takeshita T, Suzuki N, Nakano Y, et al. Discrimination of the oral microbiota associated with high hydrogen sulfide and methyl mercaptan production. Sci Rep 2012;2:215.
    Pubmed KoreaMed CrossRef
  24. Yaegaki K, Sanada K. Biochemical and clinical factors influencing oral malodor in periodontal patients. J Periodontol 1992;63:783-789.
    Pubmed CrossRef
  25. Vaiserman A, Romanenko M, Piven L, et al. Differences in the gut Firmicutes to Bacteroidetes ratio across age groups in healthy Ukrainian population. BMC Microbiol 2020;20:221.
    Pubmed KoreaMed CrossRef
  26. Nomura Y, Kakuta E, Kaneko N, Nohno K, Yoshihara A, Hanada N. The oral microbiome of healthy Japanese people at the age of 90. Applied Sci 2020;10:6450.
    CrossRef
  27. Rizzardi KF, Indiani C, Mattos-Graner RO, de Sousa ET, Nobre-Dos-Santos M, Parisotto TM. Firmicutes levels in the mouth reflect the gut condition with respect to obesity and early childhood caries. Front Cell Infect Microbiol 2021;11:593734.
    Pubmed KoreaMed CrossRef
  28. Yeh CK, Johnson DA, Dodds MW. Impact of aging on human salivary gland function: a community-based study. Aging (Milano) 1998;10:421-428.
    Pubmed CrossRef
  29. Affoo RH, Foley N, Garrick R, Siqueira WL, Martin RE. Meta-analysis of salivary flow rates in young and older adults. J Am Geriatr Soc 2015;63:2142-2151.
    Pubmed CrossRef
  30. Vissink A, Spijkervet FK, Van Nieuw Amerongen A. Aging and saliva: a review of the literature. Spec Care Dentist 1996;16:95-103.
    Pubmed CrossRef
  31. Percival RS, Challacombe SJ, Marsh PD. Flow rates of resting whole and stimulated parotid saliva in relation to age and gender. J Dent Res 1994;73:1416-1420.
    Pubmed CrossRef
  32. Al Kibria GM, Nemirovsky A, Sharmeen A, Day B. Age-stratified prevalence, treatment status, and associated factors of hypertension among US adults following application of the 2017 ACC/AHA guideline. Hypertens Res 2019;42:1631-1643.
    Pubmed CrossRef
  33. Sinclair A, Saeedi P, Kaundal A, Karuranga S, Malanda B, Williams R. Diabetes and global ageing among 65-99-year-old adults: Findings from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract 2020;162:108078.
    Pubmed CrossRef
  34. Bozdemir E, Yilmaz HH, Orhan H. Oral mucosal lesions and risk factors in elderly dental patients. J Dent Res Dent Clin Dent Prospects 2019;13:24-30.
    Pubmed KoreaMed CrossRef
  35. Elmi Rankohi Z, Shabanian M, Maleki D. Oral manifestations of patients taking anti-hypertensive medications. J Iran Dent Assoc 2020;32:83-88.
    CrossRef
  36. Kim HC, Lee H, Lee HH, et al.; Korean Society of Hypertension (KSH)-Hypertension Epidemiology Research Working Group. Korea Hypertension Fact Sheet 2023: analysis of nationwide population-based data with a particular focus on hypertension in special populations. Clin Hypertens 2024;30:7.
    Pubmed KoreaMed CrossRef
  37. Won KC, Kwon HS, Ko SH, et al. Diabetes fact sheet in Korea 2022. Korean Diabetes Association; 2022.
  38. Ogami K, Ueda T, Ryu M, Tajima S, Sakurai K. Evaluation of factors associated with tongue coating status in elderly with care needs. Bull Tokyo Dent Coll 2018;59:163-169.
    Pubmed CrossRef
  39. Seerangaiyan K, Jüch F, Winkel EG. Tongue coating: its characteristics and role in intra-oral halitosis and general health-a review. J Breath Res 2018;12:034001.
    Pubmed CrossRef
  40. Li Y, Cui J, Liu Y, Chen K, Huang L, Liu Y. Oral, tongue-coating microbiota, and metabolic disorders: a novel area of interactive research. Front Cardiovasc Med 2021;8:730203.
    Pubmed KoreaMed CrossRef
  41. Abbaszadeh E, Navabi N, Karimi Afshar S, Hashemipour MA. Frequency tongue coating in patients referred to Kerman Dental School and its relationship with relative factors. BMC Oral Health 2023;23:593.
    Pubmed KoreaMed CrossRef
  42. Aoyama KI, Okino Y, Yamazaki H, et al. Saliva pH affects the sweetness sense. Nutrition 2017;35:51-55.
    Pubmed CrossRef
  43. Dyasanoor S, Abdul Khader NF. Alteration in salivary properties and taste perception in OSMF. Contemp Clin Dent 2016;7:146-152.
    Pubmed KoreaMed CrossRef


Title_page_TemplateEngKor
Body_page_TemplateEngKor
December 2024, 49 (4)